Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Central Nervous System Diseases

3,4-dihydroxyphenylacetic acid has been researched along with Central Nervous System Diseases in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Revuelta, M1
Romero-Ramos, M1
Venero, JL1
Millan, F1
Machado, A1
Cano, J1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Central Nervous System Diseases

ArticleYear
Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet.
    Neuroscience, 1997, Volume: 77, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Ascorbic Acid Def

1997